NanoViricides Inc. (NNVC)

[arvitar]

In 2013, the company claimed to have nine products undergoing animal testing, two candidates ready to begin clinical trials within the year, and every large pharma in the world wanting to do licensing deals.
http://www.biopharma-reporter.com/Upstream-Processing/NanoViricides-Builds-Plant-to-Prep-for-Viral-Penicillin-Pipeline

Today, just four years and $40 MILLION later, the company is waiting for "skin patch" studies to be repeated, and boasts about presenting a meeting abstract on cell culture studies.

Remarkably, Seymour managed to achieve all of this success while only paying himself and the other founder annual compensation packages of a tad over $700,000.00 each!

Today the company bank account is running on fumes.

They don't have even a single lead candidate identified, and have no hope of generating revenue before running out of cash.

Raging success, indeed!!!